178 research outputs found

    VirtualEar: Diseño y construcción de un audiómetro virtual

    Get PDF
    Se desarrolló un audiómetro virtual en la plataforma de instrumentación virtual Labview 7.1. VirtualEar es un sistema que permite evaluar la capacidad auditiva mediante la realización de una prueba de audiometría aérea con posibilidad de enmascaramiento para detectar la audición cruzada. La audiometría se realiza reproduciendo tonos puros en el intervalo de frecuencias audibles (125Hz-8000Hz) con intensidad de presión sonora (SPL) variable en un rango de 0dB a 110dB. El enmascaramiento consiste en enviar una señal de ruido blanco al oído opuesto del que se está evaluando la capacidad auditiva. Ambas señales se emiten por dos canales separados y conforme se hace la prueba se van detectando los umbrales de mínima presión sonora audible. El audiómetro virtual VirtualEar permite generar y guardar la información en tablas, gráficos y reportes. Además permite manejar archivos de cada paciente e imprimir resultados.A virtual audiometer was developed using the virtual instrumentation platform Labview7.1. VirtualEar is a system that permits the evaluation of the audible capacity of a person, through an audiometric prove by air, with masking, to detect the crossed audition. The audiometry is done producing pure tones in the audible frequency’s range (125Hz-8000Hz) with pressure intensity that varies in a range from 0dB to 100dB. Masking consists on sending a white noise signal to the opposite ear of the one that is being tested. Both signals are emitted through two separate channels, and in that way, the threshold of minimum audible pressure is detected. VirtualEar also permits to generate and save the information in tables, graphics and reports. Furthermore, it’s possible to control each patient’s files and print the results

    La justicia transicional en los acuerdos de la Habana

    Get PDF
    Respondiendo a la apuesta y al compromiso de EAFIT con el esfuerzo actual de terminación negociada del conflicto armado interno colombiano, desde septiembre del año pasado el Departamento de Gobierno y Ciencias Políticas de la Escuela de Humanidades de la Universidad emprendió el proyecto de publicación de una serie de Cuadernos de Trabajo como una aproximación académica y cívico-política preliminar al proceso de paz y a los acuerdos que en el transcurso del mismo han ido suscribiendo paulatinamente el Gobierno Nacional y la guerrilla de las FARC. A esta iniciativa ha querido contribuir la Escuela de Derecho de la Universidad mediante la elaboración del Cuaderno de Trabajo relativo al “Acuerdo sobre las Víctimas del Conflicto” dado a conocer a la opinión pública el pasado mes de diciembre. Este acuerdo crea el así llamado “Sistema Integral de Verdad, Justicia, Reparación y No Repetición” (SIVJRNR) y ha sido considerado casi unánimemente como el punto de inflexión o de “no retorno” en el intento de alcanzar un acuerdo de paz definitivo dada la enorme dificultad que supuso convenir un sistema de justicia transicional. En sintonía con la finalidad que persigue el proyecto, los aportes realizados por los profesores de las distintas áreas de la Escuela que participaron en la confección de este Cuaderno, no sólo buscan contribuir con el análisis teórico y/o académico de los distintos componentes del sistema de justicia transicional pactado, sino también con la divulgación y la comprensión del mismo y de sus implicaciones tanto por parte de los distintos sectores de la sociedad como por parte de la población en general; así mismo, procuran establecer un canal de comunicación efectivo con quienes tienen en sus manos la implementación jurídica del acuerdo. Una vez más, agradecemos profundamente a la Asociación Nacional de Empresarios (Andi) y la Fundación para el Progreso de Antioquia (Proantioquia) por la colaboración y el apoyo ofrecidos para la realización del presente Cuaderno y para la satisfactoria materialización de este proyecto en su conjunto

    Atracción de escolítidos a trampas cebadas con etanol y monoterpenos en montes de Pinus pinea

    Get PDF
    Se presentan resultados de ensayos de campo para la atracción de escolítidos mediante el empleo de trampas cebadas (tipo Crossvane) con compuestos de presumible actividad cairomonal. Se realizaron tres experimentos (diciembre-2010 a enero-2011, abril a mayo de 2011 y octubre a noviembre de 2011) en cuatro parcelas con actividad relevante de Tomicus destruens y similar estado selvícola (términos municipales de Cartaya y Aljaraque. Huelva). Los objetivos parciales fueron: comparar la evolución temporal de capturas, probar la eficacia de distintas dosis de etanol y su actividad sinérgica con a-pineno, y explorar la actividad de monoterpenos en solitario o combinados (a-pineno, limoneno y terpinoleno). Seis especies de Scolytinae fueron capturadas de forma mayoritaria: T. destruens, Orthotomicus erosus, Hylastes linearis, Crypturgus mediterraneus, Carphoborus pini e Hylurgus ligniperda. Las combinaciones que emitieron la mezcla de etanol y a-pineno en diversas dosis capturaron más T. destruens y O. erosus que las que emitieron etanol solamente, aunque las diferencias no fueron significativas. En primavera abundaron H. linearis y C. mediterraneus. La presencia de limoneno pareció reducir las capturas de T. destruens. El impacto de captura de varias especies depredadoras (Thanasimus formicarius, Rhizophagus spp. y Aulonium ruficorne) que se redujo notablemente en trampas provistas de rejilla y ranuras de escape

    Diagnostic accuracy of cyst fluid amphiregulin in pancreatic cysts

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Accurate tests to diagnose adenocarcinoma and high-grade dysplasia among mucinous pancreatic cysts are clinically needed. This study evaluated the diagnostic utility of amphiregulin (AREG) as a pancreatic cyst fluid biomarker to differentiate non-mucinous, benign mucinous, and malignant mucinous cysts.</p> <p>Methods</p> <p>A single-center retrospective study to evaluate AREG levels in pancreatic cyst fluid by ELISA from 33 patients with a histological gold standard was performed.</p> <p>Results</p> <p>Among the cyst fluid samples, the median (IQR) AREG levels for non-mucinous (n = 6), benign mucinous (n = 15), and cancerous cysts (n = 15) were 85 pg/ml (47-168), 63 pg/ml (30-847), and 986 pg/ml (417-3160), respectively. A significant difference between benign mucinous and malignant mucinous cysts was observed (<it>p </it>= 0.025). AREG levels greater than 300 pg/ml possessed a diagnostic accuracy for cancer or high-grade dysplasia of 78% (sensitivity 83%, specificity 73%).</p> <p>Conclusion</p> <p>Cyst fluid AREG levels are significantly higher in cancerous and high-grade dysplastic cysts compared to benign mucinous cysts. Thus AREG exhibits potential clinical utility in the evaluation of pancreatic cysts.</p

    Defective formation of IgA memory B cells, Th1 and Th17 cells in symptomatic patients with selective IgA deficiency

    Get PDF
    Objective: Selective IgA deficiency (sIgAD) is the most common primary immunodeficiency in Western countries. Patients can suffer from recurrent infections and autoimmune diseases because of a largely unknown aetiology. To increase insights into the pathophysiology of the disease, we studied memory B and T cells and cytokine concentrations in peripheral blood. Methods: We analysed 30 sIgAD patients (12 children, 18 adults) through detailed phenotyping of peripheral B-cell, CD8+ T-cell and CD4+ T-cell subsets, sequence analysis of IGA and IGG transcripts, in vitro B-cell activation and blood cytokine measurements. Results: All patients had significantly decreased numbers of T-cell-dependent (TD; CD27+) and T-cell-independent (TI; CD27−) IgA memory B cells and increased CD21low B-cell numbers. IgM+IgD− memory B cells were decreased in children and normal in adult patients. IGA and IGG transcripts contained normal SHM levels. In sIgAD children, IGA transcripts more frequently used IGA2 than controls (58.5% vs. 25.1%), but not in adult patients. B-cell activation after in vitro stimulation was normal. However, adult sIgAD patients exhibited increased blood levels of TGF-β1, BAFF and APRIL, whereas they had decreased Th1 and Th17 cell numbers. Conclusion: Impaired IgA memory formation in sIgAD patients is not due to a B-cell activation defect. Instead, decreased Th1 and Th17 cell numbers and high blood levels of BAFF, APRIL and TGF-β1 might reflect disturbed regulation of IgA responses in vivo. These insights into B-cell extrinsic immune defects suggest the need for a broader immunological focus on genomics and functional analyses to unravel the pathogenesis of sIgAD

    The Fourteenth Data Release of the Sloan Digital Sky Survey: First Spectroscopic Data from the extended Baryon Oscillation Spectroscopic Survey and from the second phase of the Apache Point Observatory Galactic Evolution Experiment

    Get PDF
    The fourth generation of the Sloan Digital Sky Survey (SDSS-IV) has been in operation since July 2014. This paper describes the second data release from this phase, and the fourteenth from SDSS overall (making this, Data Release Fourteen or DR14). This release makes public data taken by SDSS-IV in its first two years of operation (July 2014-2016). Like all previous SDSS releases, DR14 is cumulative, including the most recent reductions and calibrations of all data taken by SDSS since the first phase began operations in 2000. New in DR14 is the first public release of data from the extended Baryon Oscillation Spectroscopic Survey (eBOSS); the first data from the second phase of the Apache Point Observatory (APO) Galactic Evolution Experiment (APOGEE-2), including stellar parameter estimates from an innovative data driven machine learning algorithm known as "The Cannon"; and almost twice as many data cubes from the Mapping Nearby Galaxies at APO (MaNGA) survey as were in the previous release (N = 2812 in total). This paper describes the location and format of the publicly available data from SDSS-IV surveys. We provide references to the important technical papers describing how these data have been taken (both targeting and observation details) and processed for scientific use. The SDSS website (www.sdss.org) has been updated for this release, and provides links to data downloads, as well as tutorials and examples of data use. SDSS-IV is planning to continue to collect astronomical data until 2020, and will be followed by SDSS-V.Comment: SDSS-IV collaboration alphabetical author data release paper. DR14 happened on 31st July 2017. 19 pages, 5 figures. Accepted by ApJS on 28th Nov 2017 (this is the "post-print" and "post-proofs" version; minor corrections only from v1, and most of errors found in proofs corrected

    Lovastatin delays infection and increases survival rates in AG129 mice infected with dengue virus serotype 2

    Get PDF
    ABSTARCT: It has been reported that treatment of DENV-infected cultures with Lovastatin (LOV), can affect viral assembly. The objective of this study was to evaluate the effect of LOV on the survival rate and viremia levels of DENV-2-infected AG129 mice. Methodology/Principal Findings: Mice were inoculated with 16106 plaque-forming units (PFU/ml) of DENV-2 and treated with LOV (200 mg/kg/day). Pre-treatment with one or three doses of LOV increased the survival rate compared to untreated mice (7.3 and 7.1 days, respectively, compared to 4.8 days). Viremia levels also decreased by 21.8% compared to untreated mice, but only in the group administered three doses prior to inoculation. When LOV was administered after viral inoculation, the survival rate increased (7.3 days in the group treated at 24 hpi, 6.8 days in the group treated at 48 hpi and 6.5 days in the group treated with two doses) compared to the untreated group (4.8 days). Interestingly, the serum viral titer increased by 24.6% in mice treated at 48 hpi with a single dose of LOV and by 21.7% in mice treated with two doses (at 24 and 48 hpi) of LOV compared to untreated mice. Finally histopathological changes in the liver and spleen in infected and untreated mice included massive extramedullary erythropoiesis foci and inflammatory filtration, and these characteristics were decreased or absent in LOV-treated mice. Conclusions/Significance: Our results suggest that the effect of LOV on viremia depends on the timing of treatment and on the number of doses administered. We observed a significant increase in the survival rate in both schemes due to a delay in the progression of the disease. However, the results obtained in the post-treatment scheme must be handled carefully because this treatment scheme increases viremia and we do not know how this increase could affect disease progression in humans

    Higher Expression of CCL2, CCL4, CCL5, CCL21, and CXCL8 Chemokines in the Skin Associated with Parasite Density in Canine Visceral Leishmaniasis

    Get PDF
    Several previous studies correlated immunopathological aspects of canine visceral leishmaniasis (CVL) with tissue parasite load and/or the clinical status of the disease. Recently, different aspects of the immune response in Leishmania-infected dogs have been studied, particularly the profile of cytokines in distinct compartments. However, the role of chemokines in disease progression or parasite burdens of the visceralising species represents an important approach for understanding immunopathology in CVL. We found an increase in inflammatory infiltrate, which was mainly composed of mononuclear cells, in the skin of animals presenting severe forms of CVL and high parasite density. Our data also demonstrated that enhanced parasite density is positively correlated with the expression of CCL2, CCL4, CCL5, CCL21, and CXCL8. In contrast, there was a negative correlation between parasite density and CCL24 expression. These findings represent an advance in the knowledge of the involvement of skin inflammatory infiltrates in CVL and the systemic consequences and may contribute to developing a rational strategy for the design of new and more efficient prophylactic tools and immunological therapies against CVL

    Rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART): study protocol for a randomized controlled trial

    Get PDF
    BACKGROUND: Acute respiratory distress syndrome (ARDS) is associated with high in-hospital mortality. Alveolar recruitment followed by ventilation at optimal titrated PEEP may reduce ventilator-induced lung injury and improve oxygenation in patients with ARDS, but the effects on mortality and other clinical outcomes remain unknown. This article reports the rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART). METHODS/DESIGN: ART is a pragmatic, multicenter, randomized (concealed), controlled trial, which aims to determine if maximum stepwise alveolar recruitment associated with PEEP titration is able to increase 28-day survival in patients with ARDS compared to conventional treatment (ARDSNet strategy). We will enroll adult patients with ARDS of less than 72 h duration. The intervention group will receive an alveolar recruitment maneuver, with stepwise increases of PEEP achieving 45 cmH2O and peak pressure of 60 cmH2O, followed by ventilation with optimal PEEP titrated according to the static compliance of the respiratory system. In the control group, mechanical ventilation will follow a conventional protocol (ARDSNet). In both groups, we will use controlled volume mode with low tidal volumes (4 to 6 mL/kg of predicted body weight) and targeting plateau pressure 6430 cmH2O. The primary outcome is 28-day survival, and the secondary outcomes are: length of ICU stay; length of hospital stay; pneumothorax requiring chest tube during first 7 days; barotrauma during first 7 days; mechanical ventilation-free days from days 1 to 28; ICU, in-hospital, and 6-month survival. ART is an event-guided trial planned to last until 520 events (deaths within 28 days) are observed. These events allow detection of a hazard ratio of 0.75, with 90% power and two-tailed type I error of 5%. All analysis will follow the intention-to-treat principle. DISCUSSION: If the ART strategy with maximum recruitment and PEEP titration improves 28-day survival, this will represent a notable advance to the care of ARDS patients. Conversely, if the ART strategy is similar or inferior to the current evidence-based strategy (ARDSNet), this should also change current practice as many institutions routinely employ recruitment maneuvers and set PEEP levels according to some titration metho
    corecore